Skip to Main Content

Paper Details

Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity.
bioRxiv
23
2020
ACE2, COVID-19, SARS-CoV, SARS-CoV-2, SARS-CoV-2 spike, SARS-CoV-2 spike protein, angiotensin, bacterial glycosidases, genomes, glycosidases, human, human H1299, human H1299 protein lung adenocarcinoma cells, lung adenocarcinoma, patients, severe acute respiratory syndrome, severe acute respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus (SARS-CoV-2) spike protein

Datasets

Release 1.2